dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.contributorUniv Bandeirante São Paulo
dc.contributorDuke Univ
dc.creatorBlay, Sergio L. [UNIFESP]
dc.creatorFillenbaum, Gerda G.
dc.creatorPitta, Jose C. [UNIFESP]
dc.creatorPeluso, Erica T.
dc.date.accessioned2016-01-24T14:37:16Z
dc.date.accessioned2022-10-07T20:50:58Z
dc.date.available2016-01-24T14:37:16Z
dc.date.available2022-10-07T20:50:58Z
dc.date.created2016-01-24T14:37:16Z
dc.date.issued2014-05-01
dc.identifierInternational Clinical Psychopharmacology. Philadelphia: Lippincott Williams & Wilkins, v. 29, n. 3, p. 157-165, 2014.
dc.identifier0268-1315
dc.identifierhttp://repositorio.unifesp.br/handle/11600/37747
dc.identifier10.1097/YIC.0000000000000008
dc.identifierWOS:000334103600004
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4023813
dc.description.abstractThe objective of this study was to examine the prevalence and characteristics of adult psychotropic medication use in São Paulo, Brazil. Information on lifetime and 12-month psychotropic medication use, and psychiatric status was obtained from a representative sample of 2000 adults aged 18-65 years in São Paulo, Brazil. Lifetime and 12-month use of psychotropic medications was 16.8 and 7.1%, respectively. of the 22.8% of patients with current psychiatric problems, 29.5% reported lifetime use and 15.8% (5.6% of the sample) reported 12-month use (anxiolytics: 2.7%, antidepressants: 1.8%, alternative medicines: 0.9%, antipsychotics: 0.4%, mood stabilizers: 0.4%, hypnotics: 0.3%; multiple class use occurred). the most frequent prescribers were psychiatrists and general practitioners. Determinants of use included identification as a psychiatric case (four-fold increased odds), being female (three-fold increase), age (4-5% per additional year), and lower odds if married. Education, employment status, and birth in São Paulo were not associated with use. Income did not affect anxiolytic use, but antidepressant and alternative medicine use was associated with higher income. These results show that psychotropic drug use was comparatively low. Only 15.8% of patients with psychiatric problems reported recent psychotropic use. Comparable with other studies, use was greater among women and increased with age.
dc.languageeng
dc.publisherLippincott Williams & Wilkins
dc.relationInternational Clinical Psychopharmacology
dc.rightsAcesso restrito
dc.subjectmiddle-income country
dc.subjectpsychiatric problems
dc.subjectantidepressants
dc.subjectpharmacoepidemiology
dc.subjectdepression
dc.subjectanxiolytics
dc.subjectBrazil
dc.subjectpsychotropic drugs
dc.titleFactors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil
dc.typeArtigo


Este ítem pertenece a la siguiente institución